Anergis anergis.ch


Public lists: Pharma Startups (4732)

Anergis is a clinical-stage biopharmaceutical company based in Switzerland. Anergis discovers and develops synthetic allergy vaccines with the aim to provide allergy patients and doctors with a significantly improved treatment option: ultra-fast desensitization. Anergis COP allergy vaccines are pharmaceutical-grade products based on Contiguous Overlapping Peptides (COPs) and only need to be administered for 2 months in order to achieve long-lasting desensitization.

Anergis is a clinical-stage biopharmaceutical company based in Switzerland. Anergis discovers and develops synthetic allergy vaccines with the aim to provide allergy patients and doctors with a significantly improved treatment option: ultra-fast dese...Show all

Company (Alive / Active)

Phone: +41 21 651 92 20

Fax:

BiopĂ´le III
Route de la Corniche 9B
Epalinges, CH-1066
Switzerland

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
Anergis $48.7M Apr 4, 2016

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related Anergis Jobs

jobs by Indeed job
						search

Investors

Investor Investor Type Location Participating Rounds
Sunstone CapitalVenture CapitalCopenhagen, DenmarkSeries B - II, Series B, Series A - II, Series A
Vinci CapitalPrivate EquityLausanne, SwitzerlandSeries B - II, Series B, Series A - II, Series A
BioMedPartnersVenture CapitalZurich, SwitzerlandSeries B - II, Series B, Series A - II
WJFSOtherSeries B - II, Series B
See all 4 investors
There is no Competitors data available for this company. Please select another tab.